EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Sperm chromatin structure assay versus sperm chromatin dispersion kits: Technical repeatability and choice of assisted reproductive technology procedure

Vidya Laxme B, Silviya Stephen, Ramyashree Devaraj, Sridurga Mithraprabhu, Ricardo P Bertolla, Tara Mahendran

Clinical and Experimental Reproductive Medicine · 01.12.2020 · 47 (4) · 277-283

DOI: 10.5653/cerm.2020.03860 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Reproductive Medicine, erschienen am 01.12.2020. Verfasst von Vidya Laxme B und 5 weiteren Autor:innen. Beteiligte Einrichtung: Andrology Center, Coimbatore, India. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The sperm DNA fragmentation index (DFI) guides the clinician’s choice of an appropriate assisted reproductive technology (ART) procedure. The DFI can be determined using commercially available methodologies, including sperm chromatin dispersion (SCD) kits and sperm chromatin structure assay (SCSA). Currently, when DFI is evaluated using SCD kits, the result is analyzed in reference to the SCSA-derived threshold for the choice of an ART procedure. In this study, we compared DFI values obtained using SCSA with those obtained using SCD and determined whether the difference affects the choice of ART procedure.

Methods

We compared SCSA to two SCD kits, CANfrag (n=36) and Halosperm (n=31), to assess the DFI values obtained, the correlations between tests, the technical repeatability, and the impact of DFI on the choice of ART.

Results

We obtained higher median DFI values using SCD kits than when using SCSA, and this difference was significant for the CANfrag kit (p

Schlagwörter

Stichwörter der Autor:innen

Assisted reproductive technologyDNA fragmentationMale infertilitySperm

Autor:innen und Institutionen

  • Andrology Center, Coimbatore, India.
  • Australian Centre for Blood Diseases, Alfred Hospital, Monash University, Melbourne, Australia.
  • Department of Surgery, Division of Urology, Sao Paulo Federal University, Sao Paulo, Brazil.

Zitieren

APA

B, V. L., Stephen, S., Devaraj, R., Mithraprabhu, S., Bertolla, R. P., & Mahendran, T. (2020). Sperm chromatin structure assay versus sperm chromatin dispersion kits: Technical repeatability and choice of assisted reproductive technology procedure. Clinical and Experimental Reproductive Medicine, 47(4), 277-283. https://doi.org/10.5653/cerm.2020.03860

Vancouver

B VL, Stephen S, Devaraj R, Mithraprabhu S, Bertolla RP, Mahendran T. Sperm chromatin structure assay versus sperm chromatin dispersion kits: Technical repeatability and choice of assisted reproductive technology procedure. Clinical and Experimental Reproductive Medicine. 2020;47(4):277-283. doi:10.5653/cerm.2020.03860

BibTeX
@article{B2020,
  author = {B, Vidya Laxme and Stephen, Silviya and Devaraj, Ramyashree and Mithraprabhu, Sridurga and Bertolla, Ricardo P and Mahendran, Tara},
  title = {Sperm chromatin structure assay versus sperm chromatin dispersion kits: Technical repeatability and choice of assisted reproductive technology procedure},
  journal = {Clinical and Experimental Reproductive Medicine},
  year = {2020},
  volume = {47},
  number = {4},
  pages = {277--283},
  doi = {10.5653/cerm.2020.03860}
}
Kostenlos starten →